Drug delays type 1 diabetes onsetAt a Glance In a clinical trial, the drug teplizumab delayed type 1 diabetes onset and improved insulin production in high-risk individuals. The results support the use of the drug for delaying or preventing type 1 diabetes. Results from a clinical trial published in 2019 showed that a two-week course of the drug teplizumab delayed the onset of type 1 diabetes by two years and halved the rate of diabetes diagnoses. “If approved for use, this will be the first drug to delay or prevent type 1 diabetes,” Herold notes. But even delaying type 1 diabetes onset can make a big difference in the lives of those at high risk.
At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.